Alcidion Group

Alcidion Group Buyback Yield

Buyback Yield of Alcidion Group (ALC.AX) as of Nov 11, 2026.

Buyback Yield

0.00

Last updated:

Buyback Yield of Alcidion Group is 2026 0.00 . Buyback Yield of Alcidion Group was 2025 0.00 . It decreases by % lower compared to the previous year.

The Alcidion Group Buyback Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Buyback Yield
Date
Buyback Yield
Jan 1, 2019
0.00 AUD
Jan 1, 2020
11.44 AUD
Jan 1, 2021
13.03 AUD
Jan 1, 2022
38.68 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.30 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026
0.00 AUD
The Alcidion Group Buyback Yield history
YEARBuyback YieldYoY
0.00—
0.00-100.00%
0.30 %—
0.00-100.00%
38.68 %+196.78%
13.03 %+13.93%
11.44 %—
0.00—
0.00-100.00%
0.17 %-67.03%
0.51 %0.00%
0.51 %0.00%
0.51 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alcidion Group Stock analysis

What does Alcidion Group do? Alcidion Group Ltd. generates revenue through the development and licensing of its healthcare software products, including Miya Precision, Miya Observations, Flow, Task Management, and PAS, marketed under the Miya brand. The company also resells selected healthcare software from strategic partners and provides implementation, support, maintenance, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product Miya Precision, a FHIR-event platform-based solution, supports clinical and operational applications, while Smartpage offers hospital communication and task management via smartphone and web. The firm serves over 400 hospitals across its key markets. Miya Precision and its associated modules form the core of Alcidion's product portfolio, targeting hospitals seeking integrated clinical solutions. Smartpage, Patientrack, and Silverlink PCS complement these offerings, catering to diverse healthcare communication and operational needs. The company’s revenue streams are driven by direct sales of software licenses, ongoing service contracts, and partner resales, with a focus on the Australian, New Zealand, and UK healthcare sectors. Alcidion’s business model emphasizes software licensing and service delivery, with Miya Precision as the primary revenue generator. The company’s strategic partnerships enable it to resell third-party software, expanding its product range without additional development costs. Healthcare institutions in Australia, New Zealand, and the United Kingdom are the primary buyers, leveraging Alcidion’s solutions for improved clinical workflows and operational efficiency. Alcidion Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcidion Group stock

On Eulerpool you can find the complete historical development of Buyback Yield Alcidion Group since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's Alcidion Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Alcidion Group

All Key Metrics — Alcidion Group